The Cooper Companies, Inc. (COO)
NASDAQ: COO · Real-Time Price · USD
81.40
+4.37 (5.67%)
At close: Dec 5, 2025, 4:00 PM EST
80.89
-0.51 (-0.63%)
After-hours: Dec 5, 2025, 7:55 PM EST

Company Description

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.

The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.

Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage.

This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing.

The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers.

The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

The Cooper Companies, Inc.
The Cooper Companies logo
CountryUnited States
Founded1980
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees16,000
CEOAlbert White

Contact Details

Address:
6101 Bollinger Canyon Road, Suite 500
San Ramon, California 94583
United States
Phone925 460 3600
Websitecoopercos.com

Stock Details

Ticker SymbolCOO
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearNovember - October
Reporting CurrencyUSD
CIK Code0000711404
CUSIP Number216648402
ISIN NumberUS2166485019
Employer ID94-2657368
SIC Code3851

Key Executives

NamePosition
Albert G. White IIIPresident, Chief Executive Officer and Non-Independent Director
Brian G. AndrewsExecutive Vice President, Chief Financial Officer and Treasurer
Daniel G. McBride Esq.Executive Vice President and Chief Operating Officer
Holly R. SheffieldPresident of CooperSurgical, Inc.
Gerard H. Warner IIIPresident of CooperVision, Inc.
Agostino Ricupati CPASenior Vice President and Chief Accounting Officer
Kim DuncanVice President of Investor Relations and Risk Management
Nicholas S. Khadder J.D.General Counsel and Secretary

Latest SEC Filings

DateTypeTitle
Dec 5, 202510-KAnnual Report
Dec 4, 20258-KCurrent Report
Nov 13, 2025SCHEDULE 13GFiling
Aug 28, 202510-QQuarterly Report
Aug 27, 20258-KCurrent Report
May 30, 2025SDForm - SD
May 30, 202510-QQuarterly Report
May 29, 20258-KCurrent Report
Apr 30, 20258-KCurrent Report
Apr 17, 2025SCHEDULE 13G/AFiling